Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2
Amar Sarkar, Siobhán Harty, Andrew H. Moeller, et al.
Trends in Molecular Medicine (2021) Vol. 27, Iss. 12, pp. 1115-1134
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Microbial transmission in the social microbiome and host health and disease
Amar Sarkar, Cameron J.A. McInroy, Siobhán Harty, et al.
Cell (2024) Vol. 187, Iss. 1, pp. 17-43
Open Access | Times Cited: 31
The role of gut microbiota in intestinal disease: from an oxidative stress perspective
Yiqi Sun, Xurui Wang, Lei Li, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 31
Microbiota and COVID-19: Long-term and complex influencing factors
Jiaqi Gang, Haiyu Wang, Xiangsheng Xue, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 45
The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment
Man Wang, Yuan Zhang, Chunmei Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Mild SARS-CoV-2 infection results in long-lasting microbiota instability
Vaibhav Upadhyay, Rahul K. Suryawanshi, Preston Tasoff, et al.
mBio (2023)
Open Access | Times Cited: 25
Association between Gut Microbiota and SARS-CoV-2 Infection and Vaccine Immunogenicity
Ho Yu Ng, Wai K. Leung, Ka Shing Cheung
Microorganisms (2023) Vol. 11, Iss. 2, pp. 452-452
Open Access | Times Cited: 22
Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID
A. Satyanarayan Naidu, Chin‐Kun Wang, Pingfan Rao, et al.
npj Science of Food (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 8
A phenome‐wide investigation of risk factors for severe COVID‐19
Ancha Baranova, Hongbao Cao, Shaolei Teng, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 36
Meta-analysis of 16S rRNA microbial data identified alterations of the gut microbiota in COVID-19 patients during the acute and recovery phases
Xiaomin Cheng, Yali Zhang, Yifan Li, et al.
BMC Microbiology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 34
Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways
Laure‐Alix Clerbaux, Julija Filipovska, Amalia Muñoz, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5400-5400
Open Access | Times Cited: 29
Gut microbiota in COVID-19: new insights from inside
Bingqian Zhou, Xiaoqi Pang, Jingyi Wu, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Standing the test of COVID-19: charting the new frontiers of medicine
Simon Cauchemez, Giulio Cossu, Nathalie M. Delzenne, et al.
Frontiers in Science (2024) Vol. 2
Open Access | Times Cited: 6
Long COVID-19
Isabel Rodríguez-Sánchez, Leocadio Rodríguez‐Mañas, Olga Laosa
Clinics in Geriatric Medicine (2022) Vol. 38, Iss. 3, pp. 533-544
Open Access | Times Cited: 26
Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
Laure‐Alix Clerbaux, Maria Cristina Albertini, Núria Amigó, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4464-4464
Open Access | Times Cited: 22
Sex differences and individual variability in the captive Jamaican fruit bat (Artibeus jamaicensis) intestinal microbiome and metabolome
Jade C. Riopelle, Amirhossein Shamsaddini, Myndi G. Holbrook, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Gender differences in sequelae from COVID-19 infection
Trinity Eimer, Sonia Villapol
Elsevier eBooks (2025), pp. 599-613
Closed Access
Riboflavin Supplementation Promotes Butyrate Production in the Absence of Gross Compositional Changes in the Gut Microbiota
Lei Liu, Mehdi Sadaghian Sadabad, Giorgio Gabarrini, et al.
Antioxidants and Redox Signaling (2022)
Open Access | Times Cited: 21
Is the epithelial barrier hypothesis the key to understanding the higher incidence and excess mortality during COVID‐19 pandemic? The case of Northern Italy
Silvana Fiorito, Marzia Soligo, Yadong Gao, et al.
Allergy (2022) Vol. 77, Iss. 5, pp. 1408-1417
Open Access | Times Cited: 20
Retracted: Gut microbiota and COVID‐19: A systematic review
SeyedAhmad SeyedAlinaghi, Arian Afzalian, Zahra Pashaei, et al.
Health Science Reports (2023) Vol. 6, Iss. 2
Open Access | Times Cited: 9
Coronavirus Disease 2019, Diabetes, and Inflammation: A Systemic Review
Monique R. Ferguson, Jaysonn Vel, Vincent Phan, et al.
Metabolic Syndrome and Related Disorders (2023) Vol. 21, Iss. 4, pp. 177-187
Open Access | Times Cited: 8
Mild SARS-CoV-2 infection results in long-lasting microbiota instability
Vaibhav Upadhyay, Rahul Suryawanshi, Preston Tasoff, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 9
Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19
Daizee Talukdar, Purbita Bandopadhyay, Yogiraj Ray, et al.
Gut Pathogens (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Nutraceuticals and pharmacological to balance the transitional microbiome to extend immunity during COVID-19 and other viral infections
Anju Kaushal
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Human microbiota dysbiosis after SARS-CoV-2 infection have the potential to predict disease prognosis
Jie Zhou, Xiping Yang, Y. Yang, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
Laure‐Alix Clerbaux, Maria Cristina Albertini, Núria Amigó, et al.
(2022)
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top